Data Characteristics in This Domain
Stem cell therapy pharmacovigilance data originates from clinical trial reports, real-world evidence (RWE) studies, individual case safety reports (ICSRs), literature reviews, and regulatory guidelines. These documents are typically in PDF, Word, or structured text formats (e.g., XML). Data update frequency varies; clinical trial reports are usually published after phase completion, while ICSRs accumulate continuously. Documents have complex structures, containing extensive medical terminology, abbreviations, dosage units, adverse event descriptions, patient demographics, and treatment protocols. Fields and units are specific, detailing cell types, administration routes, dosages (e.g., cells/kg), adverse reaction grading (e.g., CTCAE grades), and onset and duration times.
Constraints Imposed by These Characteristics on Document Parsing and Chunking
The complexity of stem cell therapy documents demands advanced parsing capabilities. Extensive medical jargon, abbreviations, and specific dosage units require parsers with deep domain knowledge. Without this, identification errors or information loss can occur. Nested tables, images, and captions often contain critical adverse reaction information or patient characteristics. Standard text parsing may struggle to extract this effectively. Given the time-sensitive nature of adverse reaction reporting, the parsing process must support rapid processing for urgent situations. Furthermore, structural differences across document sources—such as chapter divisions in clinical study reports versus fixed fields in case reports—mean a single chunking strategy is insufficient. More adaptive chunking methods are necessary. Accurate identification and chunking of time-series data (e.g., adverse reaction onset and resolution times) are crucial for pharmacovigilance risk assessment.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size (Chunk Length) | 800–1200 characters | Balances contextual completeness and retrieval efficiency. Avoids excessively long chunks diluting key information or overly short chunks losing context. |
Chunk Overlap Length (Chunk Overlap Length) | 100–200 characters | Ensures critical information across chunks is not fragmented, especially for adverse reaction descriptions spanning chunk boundaries. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Accounts for parsing time of large clinical trial reports or multi-page PDFs, preventing timeout failures. |
Table Recognition Mode | Intelligent recognition and extraction | Many adverse reaction data points in stem cell therapy documents are presented in tables. Ensure table content is accurately parsed and structured. |
Custom Entity Recognition | Configure cell types, adverse reaction names, dosage units | Pre-train or configure for stem cell-specific terminology and units to improve parsing accuracy, e.g., "CAR-T cells", "10^6 cells/kg", "CRS". |
Common Pitfalls
- Parsing tasks hang or return
Request Timeouterrors: This is due to excessively large document size or complex content (e.g., many images, tables), andPARSE_FILE_TIMEOUT_SECONDSbeing set too low. - Key adverse reaction information is missing from knowledge base retrieval results: The parser failed to effectively identify and extract text content from nested tables or images, preventing relevant data from being chunked.
- Partial data loss after uploading large Excel tables: The file size exceeds system processing limits, or the number of internal data rows is too high, leading to memory overflow or processing interruption during parsing.
Verification Steps
- Select a stem cell therapy clinical report with complex tables and medical terminology. Upload it and check if the parsed chunks contain key data from the tables and if medical terminology is complete.
- Upload a PDF document exceeding 50 pages. Observe the parsing task completion time to ensure it finishes within the
PARSE_FILE_TIMEOUT_SECONDSsetting. - Compare the original document with the chunked content in the knowledge base. Verify the accuracy of key adverse event descriptions, cell dosages, and administration routes. Then, use retrieval to confirm this information is recallable.
The values provided above are common starting points. Measure them against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.